The impact of physical frailty on the response to inactivated influenza vaccine in older adults

Aging (Albany NY). 2020 Dec 9;12(24):24633-24650. doi: 10.18632/aging.202207. Epub 2020 Dec 9.

Abstract

Physical frailty's impact on hemagglutination inhibition antibody titers (HAI) and peripheral blood mononuclear cell (PBMC) transcriptional responses after influenza vaccination is unclear. Physical frailty was assessed using the 5-item Fried frailty phenotype in 168 community- and assisted-living adults ≥55 years of age during an observational study. Blood was drawn before, 3, 7, and 28 days post-vaccination with the 2017-2018 inactivated influenza vaccine. HAI response to the A/H1N1 strain was measured at Days 0 and 28 using seropositivity, seroconversion, log2 HAI titers, and fold-rise in log2 HAI titers. RNA sequencing of PBMCs from Days 0, 3 and 7 was measured in 28 participants and compared using pathway analyses. Frailty was not significantly associated with any HAI outcome in multivariable models. Compared with non-frail participants, frail participants expressed decreased cell proliferation, metabolism, antibody production, and interferon signaling genes. Conversely, frail participants showed elevated gene expression in IL-8 signaling, T-cell exhaustion, and oxidative stress pathways compared with non-frail participants. These results suggest that reduced effectiveness of influenza vaccine among older, frail individuals may be attributed to immunosenescence-related changes in PBMCs that are not reflected in antibody levels.

Keywords: antibody titers; frailty; immune response; influenza; peripheral cell mediated immunity.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibody Formation / immunology*
  • Assisted Living Facilities
  • Case-Control Studies
  • Cell Proliferation*
  • Female
  • Frailty / genetics
  • Frailty / immunology*
  • Hemagglutination Inhibition Tests
  • Humans
  • Independent Living
  • Influenza Vaccines / therapeutic use*
  • Influenza, Human / prevention & control*
  • Interferons
  • Interleukin-8 / genetics
  • Interleukin-8 / immunology
  • Leukocytes, Mononuclear
  • Male
  • Middle Aged
  • Oxidative Stress / genetics
  • Oxidative Stress / immunology
  • T-Lymphocytes / immunology
  • Vaccines, Inactivated / therapeutic use*

Substances

  • CXCL8 protein, human
  • Influenza Vaccines
  • Interleukin-8
  • Vaccines, Inactivated
  • Interferons